| Product Information |
|
| Registration Number |
BR-925
|
| Generic Name |
Human Papillomavirus Vaccine [Types 16 and 18]
(Recombinant, adjuvanted, adsorbed)
|
| Brand Name |
Cervarix
|
| Dosage Strength |
Formulation:
1 dose (0.5 mL) contains:
Human Papillomavirus type 16 L1 protein*.
Human Papillomavirus type 18 L1 protein*.
.20 mcg ...... 20 mcg
*adjuvanted by AS04 containing 3-O-desacyl-4'-monophosphoryl lipid A (MPL) and Aluminum hydroxide, hydrated [Al(OH)3]
|
| Dosage Form |
Suspension for Injection (IM)
|
| Classification |
Prescription Drug (RX)
|
| Packaging |
1 mL in 3 mL Type I Glass Vial with Vaccine Vial Monitor (Box of 1's and 100's)
|
| Pharmacologic Category |
Vaccine
|
| Manufacturer |
GlaxoSmithKline Biologicals SA
|
| Country of Origin |
Belgium
|
| Trader |
N/A
|
| Importer |
GlaxoSmithKline Philippines, Inc.
|
| Distributor |
GlaxoSmithKline Philippines, Inc.
|
| Application Type |
Renewal (Reconstruction)
|
| Issuance Date |
22 February 2024
|
| Expiry Date |
23 March 2027
|